Smith & Nephew
“Market Cap $13.67 B As of May 2014
At a Glance
- Industry: Medical Equipment & Supplies
- Founded: 1937
- Country: United Kingdom
- CEO: Olivier Bohuon
- Website: www.smith-nephew.com
- Employees: 11,036
- Sales: $4.35 B
- Headquarters: London
#1360 Global 2000
- #1905 in Sales
- #1065 in Profit
- #821 in Market value
#51 Innovative Companies
Smith & Nephew Plc is a global orthopedics company. It develops, manufactures, markets and sells medical devices in the sectors of advanced medical devices and advanced wound management. The company operates in three segments: Orthopedics, Endoscopy and Advanced Wound Management. The Orthopedics segment comprises reconstruction implants, including hip, knee and shoulder joints, as well as ancillaryproducts, such as bone cement and mixing systems used in cemented reconstruction joint surgery. This segment also provides trauma fixation products consisting of internal and external devices, and shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures and clinical therapies products comprising bone growth stimulation, joint fluid therapies and outpatient spine products. The Endoscopy segment develops and commercializes minimally invasive surgery techniques, educational programs and value-added services for surgeons to treat and repair soft tissue and articulating joints. It offers specialized devices and fixation systems to repair damaged tissues; fluid management equipment for surgical access; digital cameras, digital image capture, scopes, light sources, and monitors to assist with visualization; radiofrequency wands, electromechanical and mechanical blades and hand instruments for resecting damaged tissues. The Advanced Wound Management segment offers a range of products from initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers and products for the treatment of wounds, including burns and invasive surgery. Smith & Nephew was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.“
“Smith & Nephew History
The Group has a history dating back over 150 years to the family enterprise of Thomas James Smith who opened a small pharmacy in Hull, England in 1856. On his death in 1896, his nephew Horatio Nelson Smith took over the management of the business.
By the late 1990s, Smith & Nephew had expanded into being a diverse healthcare conglomerate with operations across the globe, including various medical devices, personal care products and traditional and advanced woundcare treatments. In 1998, Smith & Nephew announced a major restructuring to focus management attention and investment on three business units — wound management, endoscopy and orthopaedics— which offered high growth and margin opportunities.
Smith & Nephew was incorporated and listed on the London Stock Exchange in 1937 and in 1999 the Group was also listed on the New York Stock Exchange. In 2001, Smith & Nephew became a constituent member of the FTSE-100 index in the UK. This means that Smith & Nephew is included in the top 100 companies traded on the London Stock Exchange measured in terms of market capitalisation.
Today, Smith & Nephew is a public limited company incorporated andheadquartered in the UK and doing business in many countries around the world.”
*Information from Forbes.com and Smith-nephew.com
**Video published on YouTube by “investmentinsight“